From The St. Louis Busienss Journal

by Amir Kurtovic

Aug. 22 is an important date for entrepreneurs and investors alike. That's when the Securities and Exchange Commission is set to take some kind of action on key provisions of the Jumpstart our Business Startup (JOBS Act) law, which was one of the only pieces of legislation signed into by by President Barack Obama to receive bipartisan support this year.

While there are many provisions in the JOBS Act, one of the most significant changes in the law would allow companies to advertise fundraising rounds to investors, said Andy Hoyne, a Polsinelli Shughart attorney who specializes in life sciences, securities law and venture and private equity capital.

"There's a big paradigm shift in what's going on,"Hoyne said. "In the past when companies had to raise money it had to about about who you knew and contacts and maybe angel networks."

The JOBS Act is supposed to change that. Instead of having to rely on family friends and private investors, the new legislation would allow companies to advertise for investors in newspapers or online portals that many expect will be established to organize securities offerings.

About Andy Hoyne

Andrew Hoyne practices business and corporate law focused upon the representation of life sciences and other technology-based companies.

Mr. Hoyne’s life science clients have included multi-billion dollar corporations, Big Ten universities, and emerging companies in fields including pharmaceuticals, medical devices, research services, agriculture, and bio-energy. Over the past dozen years, he has represented his clients in raising over $100 million of financing from venture capital funds, angels, development organizations and other funding sources. He has also represented his clients in partnering agreements with Monsanto, Zimmer, Sangamo and other companies. Client exits have included sales to Monsanto, Viasys (now part of Carefusion) and Avant Pharmaceuticals. Prior to entering private practice, Mr. Hoyne was an in-house attorney, most recently at Invitron, a publicly-held biopharmaceutical contract manufacturing and product development company. Mr. Hoyne is vice-chair of Polsinelli Shughart’s multidisciplinary Life Sciences group.

Mr. Hoyne’s clients have also included clients in the fields of information technology; food products, ingredients and flavors; imaging devices; powders for industrial applications; spectroscopic analytical technology; and other technical and industrial applications.

Mr. Hoyne is also an active member of the firm's multi-disciplinary emerging technology company practice which assists clients in a variety of technical fields including information technology, life sciences, and energy. In St. Louis, the group works closely with Arch Grants, Capital Innovators, Olin Cup, and other programs and events in support of the St. Louis regional effort to support and encourage the establishment, funding and development of companies in these fields.

Andrew Hoyne practices business and corporate law focused upon the representation of life sciences and other technology-based companies.

Mr. Hoyne’s life science clients have included multi-billion dollar corporations, Big Ten universities, and emerging companies in fields including pharmaceuticals, medical devices, research services, agriculture, and bio-energy. Over the past dozen years, he has represented his clients in raising over $100 million of financing from venture capital funds, angels, development organizations and other funding sources. He has also represented his clients in partnering agreements with Monsanto, Zimmer, Sangamo and other companies. Client exits have included sales to Monsanto, Viasys (now part of Carefusion) and Avant Pharmaceuticals. Prior to entering private practice, Mr. Hoyne was an in-house attorney, most recently at Invitron, a publicly-held biopharmaceutical contract manufacturing and product development company. Mr. Hoyne is vice-chair of Polsinelli Shughart’s multidisciplinary Life Sciences group.

Mr. Hoyne’s clients have also included clients in the fields of information technology; food products, ingredients and flavors; imaging devices; powders for industrial applications; spectroscopic analytical technology; and other technical and industrial applications.

Mr. Hoyne is also an active member of the firm's multi-disciplinary emerging technology company practice which assists clients in a variety of technical fields including information technology, life sciences, and energy. In St. Louis, the group works closely with Arch Grants, Capital Innovators, Olin Cup, and other programs and events in support of the St. Louis regional effort to support and encourage the establishment, funding and development of companies in these fields.